Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

4DMedical (ASX:4DX) Surges as CT:VQ Adds Australian Access and an AI Partner

4DMedical (ASX:4DX) moved into focus after the shares rose 8.59% to AUD 4.30. The stock traded between AUD 3.89 and AUD 4.34, with 6,435,110 shares changing hands. The move renewed attention on the company’s latest clinical, regulatory or commercial development, while the one-year return …

Aditi Sarkar | 04 August 2026

Paradigm Biopharmaceuticals (ASX:PAR) Gains as Phase 3 Safety Review Clears the Next Gate

Paradigm Biopharmaceuticals (ASX:PAR) moved into focus after the shares rose 8.57% to AUD 0.19. The stock traded between AUD 0.175 and AUD 0.195, with 1,983,406 shares changing hands. The move renewed attention on the company’s latest clinical, regulatory or commercial development, while the one-year …

Aditi Sarkar | 04 August 2026

Prescient Therapeutics (ASX:PTX) Reaches Its High as Oncology Programmes Return to View

Prescient Therapeutics (ASX:PTX) moved into focus after the shares rose 8.24% to AUD 0.092. The stock traded between AUD 0.085 and AUD 0.092, with 1,978,935 shares changing hands. The move renewed attention on the company’s latest clinical, regulatory or commercial development, while the one-year …

Aditi Sarkar | 04 August 2026

Vitasora Health (ASX:VHL) Moves Higher as vCare Targets a Lower Cost Base

Vitasora Health (ASX:VHL) moved into focus after the shares rose 10.00% to AUD 0.011. The stock traded between AUD 0.010 and AUD 0.011, with 886,432 shares changing hands. The move renewed attention on the company’s latest clinical, regulatory or commercial development, while the one-year …

Aditi Sarkar | 04 August 2026

PYC Therapeutics (ASX:PYC) Nears AUD 2 as Its Kidney Trial Moves Into Multiple Dosing

PYC Therapeutics (ASX:PYC) moved into focus after the shares rose 9.62% to AUD 1.995. The stock traded between AUD 1.850 and AUD 2.01, with 3,435,046 shares changing hands. The move renewed attention on the company’s latest clinical, regulatory or commercial development, while the one-year …

Aditi Sarkar | 04 August 2026

Nyrada (ASX:NYR) Extends Its Run as Xolatryp Enters a Phase II Test

Nyrada (ASX:NYR) moved into focus after the shares rose 8.76% to AUD 0.745. The stock traded between AUD 0.690 and AUD 0.750, with 562,100 shares changing hands. The move renewed attention on the company’s latest clinical, regulatory or commercial development, while the one-year return …

Aditi Sarkar | 04 August 2026

Dimerix (ASX:DXB) Advances as DMX-200 Secures a New Asian Licensing Route

Dimerix (ASX:DXB) moved into focus after the shares rose 11.54% to AUD 0.29. The stock traded between AUD 0.260 and AUD 0.290, with 2,765,416 shares changing hands. The move renewed attention on the company’s latest clinical, regulatory or commercial development, while the one-year return …

Aditi Sarkar | 04 August 2026

Microba Life Sciences (ASX:MAP) Rises as SYNLAB Expands the Diagnostics Route

Microba Life Sciences (ASX:MAP) moved into focus after the shares rose 11.11% to AUD 0.05. The stock traded between AUD 0.047 and AUD 0.050, with 491,777 shares changing hands. The move renewed attention on the company’s latest clinical, regulatory or commercial development, while the …

Aditi Sarkar | 04 August 2026

Micro-X (ASX:MX1) Rebounds After World-First Human Imaging With Head CT

Micro-X (ASX:MX1) moved into focus after the shares rose 10.71% to AUD 0.031. The stock traded between AUD 0.027 and AUD 0.033, with 1,276,880 shares changing hands. The move renewed attention on the company’s latest clinical, regulatory or commercial development, while the one-year return …

Aditi Sarkar | 04 August 2026

HITIQ (ASX:HIQ) Jumps 50% as PROTEQT Pushes Further Into Consumer Sport

HITIQ (ASX:HIQ) moved into focus after the shares rose 50.00% to AUD 0.009. The stock traded between AUD 0.007 and AUD 0.009, with 2,572,702 shares changing hands. The move renewed attention on the company’s latest clinical, regulatory or commercial development, while the one-year return …

Aditi Sarkar | 04 August 2026
Support

Hi! How can we help you today?

Loading…